Market Tracker

10/23 5:16pm ET

Heron Therapeutics Inc (NASDAQ:HRTX)

15.35
Delayed Data
As of 3:59pm ET
 -0.15 / -0.97%
Today’s Change
12.21
Today|||52-Week Range
20.85
+17.18%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close15.50
Today’s open15.45
Day’s range15.05 - 15.65
Volume706,597
Average volume (3 months)767,807
Market cap$839.2M
Dividend yield--
Data as of 3:59pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)-54.76%
Earnings growth (this year)+22.92%
Earnings growth (next 5 years)+44.06%
Revenue growth (last year)--
P/E ratioNM
Price/Sales388.44
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ADROAduro Biotech Inc-0.45-4.89%
BYSIBeyondspring Inc+3.51+12.11%
ZIOPZIOPHARM Oncology In...-0.29-5.37%
TGTXTG Therapeutics Inc-0.20-2.33%
Data as of 3:59pm ET, 10/23/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.87
Annual revenue (last year)$1.3M
Annual profit (last year)-$173.1M
Net profit margin-13,537.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
San Diego, California

Forecasts